发明名称 |
Method of treating osteoarthritis with an antibody to NGF |
摘要 |
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved. |
申请公布号 |
US9353176(B2) |
申请公布日期 |
2016.05.31 |
申请号 |
US201314038349 |
申请日期 |
2013.09.26 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
MacDonald Lynn;Torres Richard;Morra Marc R.;Martin Joel H.;Reinhardt Joel C.;Tiseo Paul |
分类号 |
A61K39/395;C07K16/22;A61K45/06;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
Mallon Veronica;Bozicevic Karl |
主权项 |
1. A method for ameliorating, improving or inhibiting osteoarthritic pain in a human subject in need thereof, comprising:
administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritic pain is inhibited, ameliorated or improved, wherein the antibody or antigen-binding fragment thereof comprises: the three heavy chain CDRs (HCDR1, HCDR2 and HCDR3) contained within any one of the heavy chain variable region (HCVR) sequences encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 3, 19 and 23; and three light chain CDRs (LCDR1, LCDR2 and LCDR3) contained within any one of the light chain variable region (LCVR) sequences encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 11, 21 and 25. |
地址 |
Tarrytown NY US |